Novo Nordisk ٢٠ أبريل ٢٠٢٦ Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory - Yahoo
Novo Nordisk ٢٠ أبريل ٢٠٢٦ Novo Nordisk Details Progress of DKK 15 Billion Share Buyback Programme - TipRanks
Novo Nordisk ٢٠ أبريل ٢٠٢٦ Novo readies SCD drug from $1.1B Forma buyout for approval push after phase 3 win - Fierce Biotech
Novo Nordisk ٢٠ أبريل ٢٠٢٦ Novo posts trial win for sickle cell disease drug (NVO:NYSE) - Seeking Alpha
Novo Nordisk ١٧ أبريل ٢٠٢٦ Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied. - Investor's Business Daily
FierceBiotech ١ أبريل ٢٠٢٦ KBP hopes to revive troubled heart drug at center of deal fraud dispute with Novo Nordisk
FierceBiotech ٢٥ مارس ٢٠٢٦ Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China
FierceBiotech ١٢ مارس ٢٠٢٦ Novo Holdings sees assets shrink by a 3rd in wake of Novo Nordisk's nosediving share price
Endpoints News ١٢ مارس ٢٠٢٦ Novo Holdings’ assets fell by a third in 2025 as Novo Nordisk’s value sank
Endpoints News ٢٧ فبراير ٢٠٢٦ Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the future
FierceBiotech ٢٥ فبراير ٢٠٢٦ Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess